CALLIE DAVIDSON: Open Payments
NPI 1982289625 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,291 in 50 payments from 25 companies in 2025. Trend: 2023 $473 · 2024 $652 · 2025 $1,291
Food & beverage: $1,291
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $264 |
| Otsuka America Pharmaceutical, Inc. | 2 | $151 |
| Exact Sciences Corporation | 3 | $149 |
| ABBVIE INC. | 6 | $123 |
| PFIZER INC. | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| UCB, Inc. | 1 | $41 |
| Corcept Therapeutics | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
Products named: REXULTI, Wegovy, The Cologuard Plus Collection Kit, QULIPTA, Rybelsus, VRAYLAR, XIFAXAN, Ozempic.
Industry payments across CO — which companies pay providers there.
